Bcl11A Orchestrates Multilineage Integrity In Aging Hematopoiesis By Regulating Multipotent Progenitor Fate Decisions
As we age, our body’s ability to produce healthy blood cells can decline, a process known as aging hematopoiesis. This can lead to various health issues. Researchers have identified a key player in maintaining this vital system: a protein called Bcl11a. This protein acts as a “transcription factor,” meaning it controls which genes are active or inactive within cells, essentially guiding their development.
The study reveals that Bcl11a is crucial for the proper functioning of “hematopoietic stem cells” (HSCs) – the master cells in our bone marrow responsible for generating all types of blood cells throughout our lives. When Bcl11a is missing or not functioning correctly, these stem cells show defects that resemble those seen in an aging blood system. Specifically, the absence of Bcl11a leads to problems with cell division, including a slowdown in the “cell cycle” (the process by which cells grow and divide), which is linked to the stem cells’ inability to function properly.
The findings suggest that maintaining healthy levels of Bcl11a from early development helps ensure that our blood-forming system remains balanced and robust as we get older. It helps these “multipotent progenitor” cells (early blood cells that can develop into many different types) make the right “fate decisions” – essentially, choosing to become the correct type of mature blood cell. This understanding of Bcl11a’s role could open doors for new therapeutic strategies aimed at preserving the health of our blood system and potentially combating age-related blood disorders.
Source: link to paper